ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
Johnsonﾠ &ﾠ Johnson acquired Pfizer Consumer Healthcare for $16.6 billion
On Jun. 27, 2006, Johnsonﾠ &ﾠ Johnson announced it had acquired Pfizer Consumer Healthcare for $16.6 billion, which…
Stealth Biotherapeutics was founded
In 2006, Stealth BioTherapeutics was established as an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated…
Calistoga Pharmaceuticals was founded
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
Corixa Corp. was acquired by Glaxosmithkline for $300 million
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
The FDA’s Drug Safety Oversight Board was formed
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
Eli Lilly and Company launched new antidepressant Cymbalta
On Aug. 24, 2004, Eli Lilly and Company launched Cymbalta (duloxetine HC), a new treatment for major depression…
Medicare Prescription Drug Improvement Act required a study to make information about prescription drugs available to the visually impaired
On May 20, 2004, the Medicare Prescription Drug Improvement and Modernization Act, signed in 2003, required among other…
FDA issued public health advisory urging health professionals to limit the use of Cox-2 selective agents
In 2004, Merck announced a voluntary worldwide withdrawal of Vioxx (rofecoxib) because of an increased risk of heart…
The Emergency Use Authorization program was established
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility
In 2004, the Siteman Cancer Center established a Good Manufacturing Practice (GMP) facility, the first built in partnership…
Cialis was approved by the FDA
On Nov. 21, 2003, Cialis (tadalafil), discovered through a Glaxo Wellcome and ICOS Corp. partnership, was approved by…
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
Cialis, a medication to treat male erectile dysfunction, was approved for marketing in the European Union
On Nov. 12, 2002, Cialis, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
Diagnostics | FDA | Medicine | Pharmaceutical | Therapeutics
The Best Pharmaceuticals for Children Act improved safety and efficacy of patented and off-patent medicines for children
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
Corus Pharma was incorporated
On Jan. 12, 2001, Corus Pharma was incorporated as a private venture-backed development stage biopharmaceutical company focused on…
Wyeth Lederle Vaccines voluntarily withdrew Rotashield from the market
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
Gilead Sciences and NeXstar Pharmaceuticals announced completion of their merger
On Jul. 29, 1999, Gilead Sciences and NeXstar Pharmaceuticals announced the closing of their agreement whereby Gilead acquired…
The Tennessee Biotechnology Association was established
On Apr. 15, 1999, the Tennessee Biotechnology Association (TBA), now the Life Science Tennessee, was established. The Tennessee…
ZymoGenetics was instrumental in development of new hemophilia drug
On Mar. 27, 1999, Novo Nordisk, the ZymoGenetics parent company, announced approval of NovoSeven by the Food and…
National Black HIV/AIDS Awareness Day was founded
On Feb. 7, 1999, National Black HIV/AIDS Awareness Day was founded by five national organizations funded by the…
Jane E Henney, MD, becomes the first woman Commissioner of Food and Drugs
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
American Association for Cancer Research Scientist-Survivor Program was founded
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
Trubion Pharmaceutical was founded
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
LigoCyte Pharmaceuticals was founded
In 1998, LigoCyte Pharmaceuticals was founded in Bozeman by Robert F. Bargatze, Ph.D., and John W. Jutila, Ph.D….
The U.S. FDA approved direct to consumer advertising
On Aug. 9, 1997, the U.S. Food and Drug Administration (FDA) announced a policy that allowed pharmaceutical companies…